UTHR UNITED THERAPEUTICS PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: UTHR
- PE Ratio
As at May 16, 2025, the UTHR stock has a PE ratio of 11.28. This is based on the current EPS of $27.08 and the stock price of $305.35 per share. A decrease of 15% has been seen in the P/E ratio compared to the average of 13.3 of the last 4 quarters.
UTHR PE ratio history
The mean historical PE ratio of UNITED THERAPEUTICS over the last ten years is 12.91. The current 11.28 PE ratio is 13% below the historical average. Over the past ten years, UTHR's PE ratio was at its highest in the Jun 2015 quarter at 47.14, with a price of $173.95 and an EPS of $3.69. The Jun 2016 quarter recorded the bottom point at 4.74, with a price of $105.92 and an EPS of $22.35.
UNITED THERAPEUTICS PE ratio by year
Maximum annual increase: 254.1% in 2013
Maximum annual decrease: -76.49% in 2010
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.34 | 27.66% | $352.84 | $26.44 |
| 2023 | 10.45 | -39.94% | $219.89 | $21.04 |
| 2022 | 17.4 | -14.62% | $278.09 | $15.98 |
| 2021 | 20.38 | 56.41% | $216.08 | $10.6 |
| 2020 | 13.03 | N/A | $151.79 | $11.65 |
| 2019 | N/A | N/A | $88.08 | -$2.39 |
| 2018 | 8.04 | -48.36% | $108.9 | $13.54 |
| 2017 | 15.57 | 76.93% | $147.95 | $9.5 |
| 2016 | 8.8 | -20.36% | $143.43 | $16.29 |
| 2015 | 11.05 | -39.75% | $156.61 | $14.17 |
| 2014 | 18.34 | -43.4% | $129.49 | $7.06 |
| 2013 | 32.4 | 254.1% | $113.08 | $3.49 |
| 2012 | 9.15 | -26.21% | $53.42 | $5.84 |
| 2011 | 12.4 | -62.93% | $47.25 | $3.81 |
| 2010 | 33.45 | -76.49% | $63.22 | $1.89 |
UNITED THERAPEUTICS PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 11.38 | -14.69% | $308.27 | $27.08 |
| Dec 2024 | 13.34 | -9.5% | $352.84 | $26.44 |
| Sep 2024 | 14.74 | 6.81% | $358.35 | $24.31 |
| Jun 2024 | 13.8 | 34.37% | $318.55 | $23.09 |
| Mar 2024 | 10.27 | -1.72% | $229.72 | $22.36 |
| Dec 2023 | 10.45 | -10.84% | $219.89 | $21.04 |
| Sep 2023 | 11.72 | 0% | $225.87 | $19.28 |
| Jun 2023 | 11.72 | -17% | $220.75 | $18.83 |
| Mar 2023 | 14.12 | -18.85% | $223.96 | $15.86 |
| Dec 2022 | 17.4 | 29.75% | $278.09 | $15.98 |
| Sep 2022 | 13.41 | -20.51% | $209.38 | $15.61 |
| Jun 2022 | 16.87 | 43.45% | $235.64 | $13.97 |
| Mar 2022 | 11.76 | -42.3% | $179.41 | $15.26 |
| Dec 2021 | 20.38 | 13.92% | $216.08 | $10.6 |
| Sep 2021 | 17.89 | 5.3% | $184.58 | $10.32 |
UTHR Price vs fair value
UTHR average PE ratio chart
Currently, UTHR's PE ratio is below the 3, 5 and 10-year averages.
UTHR PE vs peers
UTHR's PE ratio is lower than its peer stocks LLY and PFE. UNITED THERAPEUTICS is presently trading at a lower PE ratio (11.28) than its peer group average of 30.81.
| Stock name | PE ratio | Market cap |
|---|---|---|
| UTHR UNITED THERAPEUTICS Corp | 11.28 | $13.77B |
| PFE Pfizer Inc | 16.42 | $129.8B |
| GILD Gilead Sciences Inc | 21.49 | $127.5B |
| CAH Cardinal Health Inc | 23.95 | $36.82B |
| LLY ELI LILLY & Co | 61.38 | $717.81B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.43B |
| BAX Baxter International Inc | N/A | $16.25B |
| CYTK Cytokinetics Inc | N/A | $3.7B |
Frequently asked questions
What is UNITED THERAPEUTICS's PE ratio?
As of May 16, 2025, UTHR stock has a price to earnings ratio of 11.28.
What is the 3-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 3-year average PE ratio for UTHR stock is 13.27.
What is the 5-year average PE ratio for UNITED THERAPEUTICS (UTHR)?
The 5-year average PE ratio for UTHR stock is 13.97.
What is the highest PE ratio for UTHR?
Over the last ten years, the quarterly PE ratio reached a historic high of 47.14 in the Jun 2015 quarter.
How does the current PE ratio for UTHR compare to its historical average?
UTHR's current price to earnings ratio is 13% below its 10-year historical average.
How is UTHR's PE ratio calculated (UNITED THERAPEUTICS PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (May 16, 2025), UNITED THERAPEUTICS's stock price is $305.35. The earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $27.08. Therefore, UNITED THERAPEUTICS's P/E ratio for today is 11.28. PE RATIO(11.28) = STOCK PRICE($305.35) / TTM EPS($27.08)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.